Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Change in Cash (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Change in Cash for 5 consecutive years, with $38.6 million as the latest value for Q4 2020.

  • On a quarterly basis, Change in Cash rose 5300.81% to $38.6 million in Q4 2020 year-over-year; TTM through Dec 2020 was $51.8 million, a 2595.06% increase, with the full-year FY2024 number at -$14.9 million, down 274.36% from a year prior.
  • Change in Cash was $38.6 million for Q4 2020 at Forte Biosciences, up from -$7.6 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $69.2 million in Q2 2017 to a low of -$38.9 million in Q4 2017.
  • A 5-year average of $4.3 million and a median of -$684000.0 in 2019 define the central range for Change in Cash.
  • Biggest YoY gain for Change in Cash was 14488.82% in 2017; the steepest drop was 2836.22% in 2017.
  • Forte Biosciences' Change in Cash stood at $1.4 million in 2016, then crashed by 2836.22% to -$38.9 million in 2017, then surged by 144.54% to $17.3 million in 2018, then crashed by 104.28% to -$742000.0 in 2019, then surged by 5300.81% to $38.6 million in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Change in Cash are $38.6 million (Q4 2020), -$7.6 million (Q3 2020), and $23.6 million (Q2 2020).